The study measured serum SIL 2R level in 59 patients with thyroid benign of malignant disease.
测定59例甲状腺良、恶性疾病患者血清中可溶性白介素受体（SIL- 2 R）。
Objective: To investigate the variation of t cell subsets and soluble interleukin 2 recepter (SIL 2r) in patients with malignant tumors.
目的：探讨恶性肿瘤患者T细胞亚群及可溶性白细胞介素2 (SIL 2r)的变化。
Methods: Monoclonal and poly - clonal dual antibody sandwich method was used to assay the levels of serum interleukin - 2 (IL - 2) and soluble interleukin - 2 receptor (SIL - 2r).
方法：采用单克隆与多克隆双抗体夹心法测定血清白介素- 2 (IL - 2)及可溶性白介素- 2受体(SIL - 2r)水平。
应用推荐